EMB protocol

chemotherapy protocol consisting of the above compounds; used in the treatment of recurrent epidermoid cancer of the head and neck

Therapeutics: 1190486
- Drug Therapy: 300623
  - Combination Drug Therapy: 12155
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - EMB protocol: 1
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - EMB protocol: 1
- Clinical Protocols
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - EMB protocol: 1
Carbohydrates: 22516
- Glycosides: 2186
  - Aminoglycosides: 5203
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Doxorubicin: 36143
        Epirubicin: 3862
        EMB protocol: 1
- Glycoconjugates: 1370
  - Glycopeptides: 1966
    - Bleomycin: 10030
      - EMB protocol: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 84029
  - Glycopeptides: 1966
    - Bleomycin: 10030
      - EMB protocol: 1
Heterocyclic Compounds: 207
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Pteridines: 149
      - Pterins: 156
        Aminopterin: 244
        Methotrexate: 24421
        EMB protocol: 1
Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Polycyclic Aromatic Hydrocarbons: 2081
        Naphthacenes
        Anthracyclines: 9615
        Daunorubicin: 2659
        Doxorubicin: 36143
        Epirubicin: 3862
        EMB protocol: 1
Polycyclic Compounds: 7
- Polycyclic Aromatic Hydrocarbons: 2081
  - Naphthacenes
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Doxorubicin: 36143
        Epirubicin: 3862
        EMB protocol: 1

Aierken Abudureheman Selected Research

Aierken Abudureheman Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure